Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Lifecore Biomedical, Inc. (LFCR) had Free Cash Flow per Share of $-0.27 for the most recently reported fiscal quarter, ending 2025-02-28.
| Income Statement Financials | |
$35.15M |
|
$-17.38M |
|
$25.31M |
|
$9.85M |
|
$44.18M |
|
$-9.03M |
|
$-5.75M |
|
$-14.78M |
|
$-14.78M |
|
$-14.77M |
|
$-14.77M |
|
$-14.77M |
|
$-14.77M |
|
$-9.03M |
|
$-6.95M |
|
37.02M |
|
37.02M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$84.21M |
|
$128.22M |
|
$153.48M |
|
$237.69M |
|
$31.12M |
|
$147.91M |
|
$159.15M |
|
$190.27M |
|
$2.23M |
|
$29.34M |
|
$47.43M |
|
37.02M |
|
| Cash Flow Statement Financials | |
$-5.55M |
|
$-4.32M |
|
$6.83M |
|
$8.46M |
|
$5.42M |
|
$-3.04M |
|
$8.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.71 |
|
-- |
|
-- |
|
0.76 |
|
3.12 |
|
28.01% |
|
-25.68% |
|
-25.68% |
|
-- |
|
-42.04% |
|
-49.44% |
|
$-9.87M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.73 |
|
1.28 |
|
70.40 |
|
-662.58% |
|
-50.33% |
|
-6.21% |
|
-7.56% |
|
$1.28 |
|
|
Free Cash Flow per Share |
$-0.27 |
$-0.15 |
|